Skip to main content

Table 1 Patient demographics, performed operations, tumor diameters, and histopathological diagnoses

From: Semi-automated computed tomography Volumetry can predict hemihepatectomy specimens’ volumes in patients with hepatic malignancy

operation

ID

Age range

Resection of MHV

Tumor entity

Intrahepatic tumor diameter(s) (CT)

Histopathological diagnosis of resected non-neoplastic liver parenchyma

left hemi-hepatectomy

1

55–59 yrs.

no

CC

1.8 cm

portal fibrosis with formation of septa

2

80–84 yrs.

no

CC

1.4 cm

extensive parenchymal necrosis

3

65–69 yrs.

yes

CC

3.2 cm

n.e.

4

60–64 yrs.

yes

CC

11.0 cm

n.e.

5

65–69 yrs.

yes

CC

5.0 cm

portal fibrosis with formation of septa

6

75–79 yrs.

no

CC

1.8 cm

portal fibrosis with formation of septa

right hemi-hepatectomy

7

60–64 yrs.

no

3 metastases (CRC)

2.2 cm to 5.7 cm

n.e.

8

70–74 yrs.

no

CC

6.4 cm

portal fibrosis with formation of septa

9

50–54 yrs.

no

6 metastases (CRC)

1.2 cm to 3.3 cm

n.e.

10

65–69 yrs.

no

5 metastasis (MM)

1.2 cm to 6.0 cm

n.e.

11

60–64 yrs.

yes

CC

2.2 cm

n.e.

12

75–79 yrs.

no

1 metastasis (CRC)

5.9 cm

n.e.

13

45–49 yrs.

no

9 metastases (GCT)

1.4 cm to 3.2 cm

n.e.

14

65–69 yrs.

no

HCC

7.7 cm

n.e.

15

60–64 yrs.

no

CC (2 foci)

1.4 cm to 10.1 cm

portal fibrosis with formation of septa

16

70–74 yrs.

no

CC

1.7 cm

n.e.

17

50–54 yrs.

no

6 metastases (TC)

1.3 cm to 2.9 cm

hepatic steatosis

extended right hemi-hepatectomy

18

30–34 yrs.

yes

CC

2.9 cm

n.e.

19

60–64 yrs.

yes

3 metastases (TC)

1.8 cm to 13.8 cm

extensive parenchymal necrosis

20

60–64 yrs.

yes

CC

11.8 cm

n.e.

21

70–74 yrs.

yes

3 metastases (CRC)

5.1 cm to 9.5 cm

n.e.

22

55–59 yrs.

yes

5 metastases (CRC)

3.8 cm to 6.7 cm

n.e.

23

65–69 yrs.

yes

CC

1.0 cm

extensive parenchymal necrosis

24

55–59 yrs.

yes

CC

1.5 cm

portal fibrosis with formation of septa

  1. f female, m male, yrs. years, MHV middle hepatic vein CC cholangiocarcinoma, GCT granulosa cell tumor, HCC hepatocellular carcinoma, MM malignant melanoma, TC thyroid carcinoma, n.e. no evidence of steatosis, portal fibrosis with formation of septa or parenchymal necrosis